Latest 10-Q quarterly reports

HG Holdings, Inc. posted a significant turnaround in its first quarter of 2026, reporting a net income of $531,000 compared to a net loss in the prior year, driven by increased title insurance premiums and substantial management fees.

Enanta Pharmaceuticals reported a Q2 2026 increase in royalty revenue driven by higher HCV sales, while research and development expenses decreased due to strategic timing of RSV trials.

Aprea Therapeutics, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing financial results, ongoing clinical trials for APR-1051 and ATRN-119, and strategic updates.

Eos Energy Enterprises reported a significant revenue increase in Q1 2026, driven by higher deliveries and average selling prices, though the company continues to operate at a net loss.

Immunic, Inc. details its Q1 2026 financial performance and ongoing clinical development of its novel oral therapies for neurologic and gastrointestinal diseases.

Zenas BioPharma, Inc. files a Form 10-Q detailing its first quarter 2026 financial results, including an amendment to its Revenue Participation Right Purchase and Sale Agreement and significant financing activities.

Compass Pathways plc announced its first quarter 2026 financial results, highlighting significant progress in its Phase 3 clinical trials for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD), alongside a substantial increase in cash reserves.

DarioHealth Corp. reported a 17.3% decrease in revenue for the first quarter of 2026 compared to the prior year, primarily due to a non-recurring pharmaceutical partner revenue in the previous period.

SS Innovations International, Inc. reported a significant increase in revenue for the first quarter of 2026, driven by strong system and instrument sales, while also addressing ongoing operational and financial considerations.

Dolphin Entertainment reported increased revenue in Q1 2026, driven by marketing and content production, but saw a higher net loss and cash burn from operations.

Daedalus Special Acquisition Corp. reports Q1 2026 results as it continues its search for an initial business combination.

VoIP-Pal.com Inc. reports a net loss of $2.03 million for the second quarter of 2026 as it continues to navigate patent litigation and operational challenges.

Karbon Capital Partners Corp. reports Q1 2026 financial results as it continues its search for an initial business combination.

FS Bancorp, Inc. filed an amendment to its Q1 2026 Form 10-Q to correct a typographical error regarding the number of outstanding common shares.

I-80 Gold Corp. reports a successful recapitalization, significantly boosting liquidity and advancing its multi-phase gold and silver development plan in Nevada.

Acumen Pharmaceuticals reported a reduced net loss and increased cash reserves in Q1 2026, driven by a private placement, while advancing its Alzheimer's drug candidates.

Fifth District Bancorp, Inc. announced a significant increase in net income for Q1 2026, driven by higher net interest income and improved asset quality.

Spartacus Acquisition Corp. II reports successful completion of its $230 million IPO and private placement, with funds now held in a trust account as it seeks a business combination.

Kopin Corporation reported a net loss of $3.8 million in Q1 2026, driven by decreased product revenues and increased operating expenses, despite new grant and collaboration income and strategic investments.

BridgeBio Oncology Therapeutics reported a net loss of $42.1 million for Q1 2026, with increased R&D expenses driven by clinical trial activities.

VS Trust files its Q1 2026 Form 10-Q, detailing the financial performance and operational status of its -1x Short VIX Futures ETF (SVIX) and 2x Long VIX Futures ETF (UVIX).

AudioEye Inc. reported an 8% increase in revenue for the first quarter of 2026, reaching $10.55 million, with Annual Recurring Revenue (ARR) growing 11% year-over-year to $41.2 million.

Veradermics, Inc. announced positive topline data from its Study 302 evaluating VDPHL01 for pattern hair loss, showing statistically significant improvements in hair count and patient-reported outcomes.

GrowGeneration Corp. announced its first quarter 2026 financial results, reporting a 7.5% increase in net sales to $38.4 million, driven by growth in its Cultivation and Gardening segment.

Hashdex Bitcoin ETF reports a significant decrease in net assets for Q1 2026 due to market fluctuations in Bitcoin.

Oak Valley Bancorp reported a slight increase in net income for Q1 2026, driven by higher net interest income and growth in earning assets, despite a decrease in total assets and deposits.

Arteris, Inc. reported a net loss of $7.96 million for the first quarter of 2026, with total revenue increasing by 39% year-over-year, driven by new customer acquisitions and the integration of Cycuity.

Resideo Technologies reported an 8.0% increase in net revenue for the first quarter of 2026, reaching $1.91 billion, but saw a decrease in income from operations and a slight dip in gross profit margin.

BTC Development Corp. reports a net income of $1.7 million for Q1 2026, primarily driven by interest income from its trust account, while continuing its search for a business combination.

T1 Energy Inc. reported a significant increase in net sales for Q1 2026, driven by expanded module production, while actively addressing trade policy and regulatory compliance.